NLRP3 has been associated with suppressing malignant progression by triggering the mitochondrial apoptotic pathway, enhancing immune-cytokine levels in the tumor microenvironment (39), and activating tumor-suppressive protein p53 in epithelial cells (42, 46, 78) (Table 2). This evidence concerns the gene NLRP3 and neoplasm.